This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Core Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BKR or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BKR vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories (CLB) Q2 Earnings Beat & Revenues Lag
by Zacks Equity Research
Core Laboratories (CLB) expects Reservoir Description revenues of $86.5-$89.5 million and Production Enhancement revenues of $44.5-$47.5 million for the third quarter of 2024.
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 4.76% and 1.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
FMC Technologies (FTI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
FMC Technologies (FTI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Core Laboratories (CLB) in Q2 Earnings?
by Zacks Equity Research
Core Laboratories (CLB) is expected to report higher revenues from the year-ago period's level. It is also likely to have incurred higher operating expenses.
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BKR or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BKR vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
by Zacks Equity Research
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
by Zacks Equity Research
Kinder Morgan's (KMI) Q1 earnings gain from increased financial contributions from the Natural Gas Pipelines, Products Pipelines and Terminals business segments.
Sunoco (SUN) Proceeds With Strategic Portfolio Optimization
by Zacks Equity Research
Despite the significant structural changes, Sunoco (SUN) maintains its financial outlook for 2024. The company projects 2024 adjusted EBITDA between $975 million and $1 billion.
What Makes Core Laboratories (CLB) a New Strong Buy Stock
by Zacks Equity Research
Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Core Laboratories (CLB) Down 0.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q4 Earnings Miss Estimates, Sales In Line
by Zacks Equity Research
Core Laboratories' (CLB) first-quarter 2024 revenues are anticipated in the $122-$128 million range, while the operating income is estimated in the band of $11.8-$14.3 million.
Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Core Laboratories (CLB) Q4 Earnings Miss Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of -5% and 0.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Liberty Oilfield Services (LBRT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Liberty Oilfield Services (LBRT) delivered earnings and revenue surprises of -5.26% and 0.58%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Reports Next Week: What You Should Expect
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Halliburton (HAL) Tops Q4 Earnings Estimates
by Zacks Equity Research
Halliburton (HAL) delivered earnings and revenue surprises of 7.50% and 0.80%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Phillips 66 (PSX) Announces $2.2B Capital Expenditure for 2024
by Zacks Equity Research
The budget aligns with Phillips 66's (PSX) strategic goal of returning $13-$15 billion to shareholders by the end of 2024.
Petrobras (PBR) Signs Rig Extension Deals With Constellation
by Zacks Equity Research
Petrobras (PBR) signs rig extension contracts with Constellation Oil Services, securing continued operations for two important rigs in its offshore drilling fleet.